INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 33 filers reported holding INMUNE BIO INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $127,000 | -62.0% | 12,473 | -27.5% | 0.00% | -50.0% |
Q3 2021 | $334,000 | +106.2% | 17,200 | +25.9% | 0.01% | +100.0% |
Q1 2021 | $162,000 | -30.5% | 13,663 | +1.0% | 0.00% | -25.0% |
Q4 2020 | $233,000 | -14.0% | 13,534 | -48.5% | 0.00% | -50.0% |
Q3 2020 | $271,000 | – | 26,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 230,500 | $2,351,000 | 1.70% |
Fermata Advisors, LLC | 17,955 | $183,000 | 0.07% |
Virtu Financial LLC | 24,364 | $249,000 | 0.02% |
YorkBridge Wealth Partners, LLC | 10,369 | $106,000 | 0.02% |
Jump Financial, LLC | 21,100 | $215,000 | 0.01% |
Financial Advocates Investment Management | 15,167 | $155,000 | 0.01% |
FNY Investment Advisers, LLC | 1,100 | $11,000 | 0.01% |
Janney Montgomery Scott LLC | 113,914 | $1,162,000 | 0.01% |
Walleye Capital LLC | 17,127 | $175,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 12,473 | $127,000 | 0.00% |